2006-11-03 -
Human health
A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients
An approach to produce an autologous therapeutic antitumor vaccine using hydroxyapatite (HA) for vaccinating cancer patients.
![Fig 6 - Ciocca - Cell Stress & Chaperones 2007](https://h5977.novius.net/storage/fm_files/hastim/publications/capture-decran-2022-09-05-a-151341.png)